Упрощенная HTML-версия
164
402.Thompson G.B. Apoptosis in the pathogenesis and treatment of disease /
G.B. Thompson // Science. – 1995. – Vol. 267. – P. 1456-1462.
403.Thornberry N.A. Caspases: enemies within / N.A. Thornberry, Y. Lazebnik
// Science. – 1998. – Vol. 28, № 5381. – P. 1312-1316.
404.312–nanometer ultraviolet B light (narrow–band UVB) induces apoptosis of
T-cells within psoriatic lesions / B.M. Ozawa, K. Ferenczi, T. Kikuchi et al.
// J. Exp. Med. − 1999. − Vol. 189, № 4. − P. 711–718.
405.Timmers H. Apoptosis in neurodegenerative diseases: to be or not to be?
Absence of proof is not of absence / H. Timmers, B. Kremer // Biomed.
Rev. – 1995. – № 4. – Р. 103-108.
406. Togami H. Proliferative responses of peripheral blood mononuclear cells
from psoriatic patients to T lymphocyte- stimulating cytokines (IL-2, IL-3,
IL-4, and granulocyte-macrophage colony-stimulating factor) and OK-432
// Ihternational Psoriasis Simposium, 6-th. – Chicago, 1994.
407.Topical retinoic acid alters the expression of cellular retinoic acid–binding
protein–I and cellular retinoic acid–binding protein–II in non–lesional but
not lesional psoriatic skin / T. Karlsson, M. Virtanen, A. Sirsjo et al. // Exp.
Dermatol. − 2002. − Vol. 11, № 2. − P. 143−152.
408.Toyoshima H. p27 a novel inhibitor of G1 cyclin Cdk protein kinase
activity, is related to p21 / H. Toyoshima, T. Hunter // Cell. – 1994.
– Vol.78, № 1. – P. 67–74.
409.Travers J.B. Epidermal HLA–DR and the enhancement of cutaneous
reactivity to superantigenic toxins in psoriasis / J.B.Travers, A. Qutayba,
D.A. Norris // J. Clin. Invest. − 1999. − Vol. 104, № 9. − P. 1181–1189.
410.Trepicchio W.L. Interleukin-11 therapy selectively downregulates type I
cytokine proinflammatory pathways in psoriasis lesions / W.L. Trepicchio,
M. Ozawa // J. Clin. Invest. – 1999. – Vol. 104, № 11. – P. 1527-1537.
411.Trimethylpsoralen bath PUVA is a remittive treatment for psoriasis
vulgaris. Evidence that epidermal immunocytes are direct therapeutic tar-
gets / T.R. Coven, F.P. Murphy, P. Gilleaudeau et al. // Arch. Dermatol. –
1998. – Vol. 134, № 10. – P. 1263-1268.
412.Tsihlias J. The prognostic significance of altered cyclin–dependent kinase
inhibitors in human cancer / J. Tsihlias, L. Kapusta, J. Singerland // Annu.
Rev. Med. – 1999. – Vol. 50. – P.401–423.
413.Tsujimoto Y. Analisis of the structure, transcripts, and protein products of
Bcl-2, the gene involved in human follicular lymphoma / Y. Tsujimoto,
C.M. Croce // Proc. Natl. Acad Sci. USA. – 1986. – Vol. 83.
– P. 5214-5218.
414.Ultraviolet B radiation–induced apoptosis in human keratinocytes: cytosolic
activation of procaspase–8 and the role of Bcl–2 / Z. Assefa, M. Garmyn,